InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by Hart Daniel R, Chief Financial Officer. Insider active across 1 companies, notably Avid Bioservices, Inc.. Cumulatively, 14 filings have been published. The latest transaction was disclosed on 30 June 2022 (J). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations14 total
€5,571450 shares@ €12.379711.8% of flow
Common Stock, $0.001 par value
SEC:0001683168-22-004766:0·
1,520 shares
Common Stock, $0.001 par value
SEC:0001683168-22-002574:0·
1,520 shares
Common Stock, $0.001 par value
SEC:0001683168-22-000216·
1,520 shares
Common Stock, $0.001 par value
SEC:0001683168-22-000216:0·
€2,488500 shares@ €4.97655.3% of flow
Common Stock, $0.001 par value
SEC:0001683168-22-000103:0·
€2,488500 shares@ €4.976512.0% of flow
Common Stock, $0.001 par value
SEC:0001683168-22-000103·
€9,369470 shares@ €19.934645.0% of flow
Common Stock, $0.001 par value
SEC:0001683168-22-000068·
€9,369470 shares@ €19.934619.9% of flow
Common Stock, $0.001 par value
SEC:0001683168-22-000068:0·
1,520 shares
Common Stock, $0.001 par value
SEC:0001683168-21-004787·
1,520 shares
Common Stock, $0.001 par value
SEC:0001683168-21-004787:0·
5,866 shares
Common Stock, $0.001 par value
SEC:0001683168-21-002950·
5,866 shares
Common Stock, $0.001 par value
SEC:0001683168-21-002950:0·
€8,9531,053 shares@ €8.502343.0% of flow
Common Stock
SEC:0001683168-21-002807·
€8,9531,053 shares@ €8.502319.0% of flow
Common Stock
SEC:0001683168-21-002807:0·
14 of 14 declarations
About Hart Daniel R
Daniel R. Hart is the Chief Financial Officer at Avid Bioservices, Inc. He is responsible for the financial management of the company, including financial planning and analysis. With a strong background in the biopharmaceutical sector, he plays a key role in Avid Bioservices' financial strategy, which focuses on the manufacturing of biological products.
